AQP1 and colorectal carcinoma: Sufficient butyrate can prevent CRC by reducing oxidative damage to DNA, inducing apoptosis of DNA-damaged cells, inhibiting the growth of tumor cells, and reducing the activity of co-oncogenes [38,39].